Associate Professor Kim Ravnskjaer joined the Department of Biochemistry and Molecular Biology (BMB) as group leader in Spring 2015. Kim Ravnskjaer earned his PhD-degree in Biomedicine from the University of Southern Denmark in 2006 and thereafter continued his research at the renowned Salk Institute for Biological Studies (https://www.salk.edu/) in La Jolla (US). At the Salk Institute, Kim specialized in the hormonal regulation and dysregulation of hepatic gene expression in Type-2 diabetes.
With a focus on the liver, the Ravnskjaer group studies tissue fibrogenesis in the context of obesity and type-2 diabetes. Fibrogenesis - scar formation - in tissues is strongly linked to organ failure and mortality. Using single-cell-resolved sequencing technologies and advanced bioimaging, the Ravnskjaer group explores the transcriptional and metabolic processes that underlie the formation and resolution of fibrosis in human patients and experimental animal models. Working towards a single-cell-resolved map of causal molecular interactions, they try to gain the insight needed to develop strategies for disease detection and intervention. Core technologies applied by the Ravnskjaer group are single-cell transcriptomics, spatial transcriptomics, single-molecule FISH, flow cytometry, and advanced mouse models of disease.
Kim Ravnskjaer is co-founder of the The Research Unit for Functional Genomics and Metabolism (https://www.sdu.dk/en/forskning/functional-genomics) and founding partner of the DNRF Center of Excellence 'ATLAS' (Center for Functional Genomic and Tissue Plasticity) (https://www.sdu.dk/en/atlas). ATLAS is a cross-faculty collaboration combining functional genomics, proteomics, preclinical, and clinical studies to investigate the plasticity of hepatic and adipose tissues in metabolic disease.
Head of research: Associate Professor, PhD Kim Ravnskjær
Researchers and research group: Kim Ravnskjær Lab
A complete list of publications by Kim Ravnskjær can be found here.